Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Jessica Spence RSU Vesting at Edgewell, Nov 9 2026

Jessica Spence, President, Americas at Edgewell Personal Care Company, filed a Form 4 on November 12, 2026, reporting the vesting and conversion of restricted stock equivalents and a related tax-withholding share disposition on November 9, 2026.

Vinay Lochav | 12 November 2026

Beindorff Plans to Sell 10,000 Lifevantage Shares

Director Michael A. Beindorff filed a Form 144 notice on November 12, 2026, disclosing a proposed sale of 10,000 shares of Lifevantage Corp common stock on NASDAQ.

Nitish Kishor | 12 November 2026

Rod Little Converts RSUs, Withholds 8,012 Shares for Tax

Edgewell Personal Care Co Chief Executive Officer Rod R. Little filed a Form 4 on November 12, 2026, reporting transactions dated November 9, 2026, related to the vesting and conversion of restricted stock equivalents originally granted November 8, 2024.

Shwetambri Chauhan | 12 November 2026

LaTanya Langley Vests 1,709 RSEs, Withholds Shares for Tax

Edgewell Personal Care Co Chief Administrative and Legal Officer LaTanya Langley filed a Form 4 on November 10, 2026, reporting transactions in Edgewell common stock dated November 9, 2026, related to the vesting of restricted stock equivalents.

Manish Choudhary | 12 November 2026

Eric W. Taylor Receives 630 Restricted Shares at $100.76

Eric W. Taylor, EVP and President of TFA at Tompkins Financial Corporation, filed a Form 4 on November 11, 2026, disclosing the acquisition of 630 shares of restricted common stock on November 9, 2026.

Nitish Kishor | 12 November 2026

Rockwell Automation Launches LogixEdge PC-Based Controller

Rockwell Automation, Inc. filed an 8-K on November 12, 2026, announcing the introduction of its LogixEdge controller, a PC-based industrial control platform combining Logix control, edge computing, and containerized applications on a single platform.

Anjali Anand | 12 November 2026

Ayrton Capital Reports 3.72% Warrant Stake in Aptevo

Ayrton Capital LLC, Alto Opportunity Master Fund, and Waqas Khatri filed an amended beneficial ownership statement with the SEC on November 12, 2026, disclosing a combined 69,965-share position in Aptevo Therapeutics Inc. common stock, representing 3.72% of the class as of September 30, 2026.

Nitish Kishor | 12 November 2026

Capuchin Capital Fund Discloses 7.3% Stake in GRI Bio

A Schedule 13G filed on November 12, 2026, by MJL Manager LLC, Michael Liu, and Capuchin Capital Fund LP discloses a combined beneficial ownership of 159,378 shares of GRI Bio, Inc. common stock, representing 7.3% of the class, as of a triggering event dated …

Anjali Anand | 12 November 2026

Ayrton Capital Discloses 9.99% Stake in Glucotrack

Ayrton Capital LLC, Alto Opportunity Master Fund SPC - Segregated Master Portfolio B, and Waqas Khatri filed a Schedule 13G with the SEC on November 12, 2026, reporting beneficial ownership of common stock in Glucotrack, Inc. as of September 30, 2026.

Nitish Kishor | 12 November 2026

Life Cycle Investment Partners Reports 8.1% Thor Industries Stake

Life Cycle Investment Partners Ltd filed a Schedule 13G with the SEC on November 12, 2026, disclosing a beneficial ownership position of 4,191,077 shares of Thor Industries Inc common stock, representing 8.1% of the class, as of the event date of September 30, 2026.

Vinay Lochav | 12 November 2026
Support

Hi! How can we help you today?

Loading…